According to documents submitted to the SEC, biotechnology company Avai Bio Inc and Ainnova Tech have agreed, as of May 7, 2026, to jointly terminate their previously established joint venture and related licensing agreements.

老虎证券2026/05/08 20:35

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Equities: Tech volatility but index holds gains – Deutsche Bank

FXStreet•2026/10/16 08:52

BUZZ - Shares of Alcoa, the aluminum producer, rise as third-quarter profits exceed expectations

路透社•2026/10/16 08:51

BUZZ - Tesla shares rise on Roadster refresh and promotion of its rocket propulsion system

路透社•2026/10/16 08:41

The onshore RMB closed at 6.6868 against the US dollar.

金色财经•2026/10/16 08:39